toosendanin has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagley, SJ; Fan, Y; Gong, Y; Jiang, H; Winkler, J; Yang, F; Ye, J; Zhang, D; Zhang, L | 1 |
| Cao, L; Jia, C; Ma, J; Qu, D; Shi, Z; Wang, H; Wang, Z; Zhang, J; Zhang, S | 1 |
2 other study(ies) available for toosendanin and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Immunosuppression Therapy; Immunotherapy; Immunotherapy, Adoptive; Macrophages; Mice; Tumor Microenvironment | 2023 |
Toosendanin Exerts an Anti-Cancer Effect in Glioblastoma by Inducing Estrogen Receptor β- and p53-Mediated Apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Estrogen Receptor beta; Flow Cytometry; Glioblastoma; Humans; Immunohistochemistry; Mice, Nude; Phytotherapy; Proto-Oncogene Proteins c-bcl-2; RNA Interference; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |